Novosanis, a medical device company and spin-off from the University of Antwerp, receives poster award for its work on skin thickness assessment using ultrasound & impact on the VAX-ID™ designs at Knowledge for Growth on May 21 in Ghent, Belgium.
On Thursday 21st of May 2015 FlandersBio organized the 11th edition of its annual life sciences convention Knowledge for Growth. Next to the lecture on "Delivery system for accurate injection of small volumes" given by CEO, Vanessa Vankerckhoven, Novosanis also presented two posters.
Timothi Van Mulder, Researcher Medical Development and Baekeland PhD Fellow at Novosanis, presented data on adult skin thickness generated using high-frequency ultrasound (poster entitled ‘HF-ultrasound to assess skin thickness and accuracy of penetration depth of VAX-ID™’). Koen Beyers, Chief Technical Officer at Novosanis presented the latest data on the Colli-Pee™ device in his poster entitled ‘Accuracy of the volume of first void urine, using a newly developed collection device’. Timothi’s poster on HF-US was awarded at Knowledge for Growth. The award was handed by Marieke Louwers (Crop Design).
“I’m really proud of winning the poster award and I would like to thank FlandersBio for this recognition” says Timothi Van Mulder, PhD Fellow at Novosanis and winner of the poster award.
VAX-ID™ is an easy to use pre-filled device suited for accurate intradermal injection, i.e. injection in the dermis, the skin layer underneath the epidermis or upper layer of the skin. Intradermal injection allows for an improved immune response. VAX-ID™ is safe to use as needle-stick injuries are avoided through a unique activation and deactivation mechanism. This platform will allow injection of different volumes, use of different needle thicknesses and length depending on the application. The device received the Belgian James Dyson award last year and is expected to be launched in about 2 to 5 years.
Novosanis designs and develops medical devices for a variety of applications, ranging from injection appliances to in vitro diagnostic accessories. Novosanis has two devices in its portfolio: VAX-ID™, suited for injections of e.g. vaccines in the dermal layer of the skin and Colli-Pee™, suited for collection of first void urine which allows detection of e.g. sexually transmitted infections and cancer biomarkers. www.novosanis.com
About Knowledge for Growth
Themed ‘A life sciences-driven network economy, looking beyond borders’, Knowledge for Growth 2015 will be jam-packed with captivating lectures and panel discussions.
Major challenges in healthcare? The future of agriculture? The latest trends in industrial biotech? Featuring four high-level plenary talks – Peter Piot (London School of Hygiene & Tropical Medicine), Young Sohn (Samsung Electronics) Kemal Malik (Bayer AG) and Paul Stoffels (Johnson & Johnson) – an industry-wide panel discussion and 30+ keynote lectures from leading companies and academics, `Knowledge for Growth’ provides vital insight into the global life sciences landscape.
The conference was held on May 21, 2015 at ICC in Ghent, Belgium. www.knowledgeforgrowth.be
Want to know more?
Koen Beyers, CTO Novosanis
Evy De Koninck, Office & Communication Manager Novosanis
T: +32 3 485 50 16